Clinical trial
Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes
NCT01215955
Study timeline
Study start (unknown)2010-12-01Date precision: month
Registry last updated2014-04-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 2unresolved
Interventions
Insulin lisproDRUG · verified · RxNorm: insulin lispro
GlargineDRUG
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Mapped research locations
HoustonTexas, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1San AntonioTexas, United States1PortlandOregon, United States1PhoenixArizona, United States1MinneapolisMinnesota, United States1JacksonvilleFlorida, United States1OrlandoFlorida, United States1Las VegasNevada, United States1Saint PetersburgRussia1LexingtonKentucky, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01215955 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.